.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Moodys
Federal Trade Commission
Chinese Patent Office
Healthtrust
Mallinckrodt
Teva
McKesson
McKinsey
US Department of Justice

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 195 46 249.1

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer HlthcareAVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINERmoxifloxacin hydrochlorideSOLUTION;IV (INFUSION)021277-001Nov 30, 2001APRXYesYes➤ Subscribe➤ SubscribeMETHOD OF COMBATING BACTERIA IN A PATIENT
Bayer HlthcareAVELOXmoxifloxacin hydrochlorideTABLET;ORAL021085-001Dec 10, 1999ABRXYesYes➤ Subscribe➤ SubscribeMETHOD OF COMBATING BACTERIA IN A PATIENT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist